openPR Logo
Press release

Cachexia Treatment Market to Record Sturdy Growth by 2025

05-16-2018 07:09 PM CET | Health & Medicine

Press release from: Transparency Market Research

Cachexia Treatment Market to Record Sturdy Growth by 2025

Cachexia is a condition associated with loss of weight and muscle mass in response to a chronic disease. The condition is a symptom of chronic disease such as cancer, diabetes, heart failure, chronic obstructive pulmonary disease etc. Amongst these, cancer is the main cause leading to cachexia. According to a study, it has been estimated that approximately 5 million Americans suffer from this condition. There are different conditions where a person loses weight; but cachexia is a condition where a person loses weight despite eating well. Usually a person who does not eat will lose fat but a person in this condition loses fat as well as muscle mass. Furthermore, it has been found that imbalance of certain substances in the body is responsible for developing cachexia. This imbalance may be due to the rise in the cytokines level in the blood which causes weight loss as cytokines are inflammatory substances.

This rise in cytokines can occur in response to chronic health conditions which trigger cachexia. It is important to diagnose cachexia in case of chronic diseases such as heart failure, cancer, diabetes, chronic obstructive pulmonary disease etc. on the basis of an estimated 9 million people affected by cachexia in industrialized regions. It is important to differentiate cachexia from sarcopenia. Sarcopenia and muscle wasting are associated with reduced exercise capacity affecting quality of life but does not involve weight loss as in cachexia. The first step in the treatment of cachexia involves resistance training to build muscle if the person is physically capable to do so since there are no medicines approved for the treatment of cachexia. However, certain off-label medications which have been used in treating cachexia involve those which reduce cytokine levels in the body, and medicines to increase appetite and sometimes growth hormones.

The Cachexia Treatment Market is forecasted to grow in the future owing to the rise in cancer patients and unmet needs to overcome cancer symptoms and difficult conditions like cachexia. In response to the requirements, many pharma companies are now in the process of developing vaccines and new drugs to combat cancer and its related challenging conditions. There are numerous drugs in the pipeline for the treatment of cachexia and some of them include Anamorelin, Bimagrumab etc.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28553

The cachexia treatment market is segmented according to drug type, diet, exercise, and distribution channel. On the basis of drug type, the market is segmented into medications that reduce cytokines in the body, stimulate appetite such as Dronabinol, mega sterol acetate and corticosteroids, or medicines that block hormones associated with cachexia. Diet changes are suggested; however, they can rarely reverse the effects of cachexia. Exercise helps in building muscle mass. If a person is physically capable, resistance training using weights or resistance bands are helpful in treating muscle loss in cachexia.

Geographically, the cachexia market is segmented into five regions namely North America, Latin America, Europe, Asia Pacific (excluding Japan), and the Middle East & Africa. Though there is high demand for cachexia treatment drugs and supplements in all the regions, the market is currently dominated by developed regions such as the United States and Europe. Countries in Asia Pacific and Rest of the World are witnessing tremendous growth in healthcare infrastructure which is expected to propel the growth of the cachexia market.

Key players in the global cachexia market include Aeterna Zentaris Inc, Aphios Corporation, Novartis AG, Helsinn Healthcare S.A., PsiOxus Therapeutics Ltd, and Obexia AG.

View Report -

https://www.transparencymarketresearch.com/cachexia-treatment-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cachexia Treatment Market to Record Sturdy Growth by 2025 here

News-ID: 1052193 • Views: 373

More Releases from Transparency Market Research

Synthetic Blood Substitutes and Blood Products Market Demand Research Report Ana …
Synthetic blood substitute or artificial blood is a replacement for blood. It generally replicates and fulfills some functions of blood and provides an alternative to blood transfusion. The main purpose of artificial blood is transportation of oxygen and carbon dioxide across the body. View Report : https://www.transparencymarketresearch.com/synthetic-blood-substitutes-blood-products-market.html Blood loss due to traumatic injuries and diseases is responsible for thousands of deaths each year. Furthermore, fresh blood can be stored for only 42
Medical Computer Carts Market Trends Research Report Analysis Revealing Key Driv …
Medical computer carts can be defined as medical carts used by medical staff for several day to day activities such as checking electronic medical records, distributing drugs, charting and EMR, medication dispensing, and nursing education. These are suitable for large hospitals, health clinics, pharmacies, and psychiatric hospitals. View Report : https://www.transparencymarketresearch.com/medical-computer-carts-market.html The global medical computer carts market has witnessed strong growth in the past few years driven by increased adoption of electronic
Impact of Outbreak of COVID-19 on Stair Lift Manufacturing Market : Global Indus …
Global Stair Lift Manufacturing Market: Overview Stair lift, commonly used in home care settings or healthcare facilities, are motorized seats which run along a rail or track and are powered by alternating current or batteries so that they can function even during power outages. Stair lifts for both straight and curved staircases are available in the market and they can be completely customized too. They are easy to operate and have
Analysis of Potential Impact of COVID-19 on Knee Implants Market
Global Stair Lift Manufacturing Market: Overview Stair lift, commonly used in home care settings or healthcare facilities, are motorized seats which run along a rail or track and are powered by alternating current or batteries so that they can function even during power outages. Stair lifts for both straight and curved staircases are available in the market and they can be completely customized too. They are easy to operate and have

All 5 Releases


More Releases for Cachexia

Cachexia Market 2020 Research by Expert
Cachexia - Pipeline Insight, 2019 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Cachexia Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought
Cancer Cachexia Market to Witness Exponential Growth by 2024
Current and ongoing clinical trials in oncology have shed light on multifactorial pathogenicity of the syndrome cancer cachexia. Understanding the mechanism of cancer cachexia has become imperative for the understanding of prognostic factors for cancer. Biopharmaceuticals seeking stronghold in the global cancer cachexia market have adopted strategies that accelerate time-to-market of novel pharmaceutical agents, observes analysts at Transparency Market Research. Top Players Adopt Strategies for Testing Multidisciplinary Combination Therapies Leading players are
Cancer Cachexia Market 2018 - Evolving Approach to Management of Cancer Cachexia
In 2018, the market size of Cancer Cachexia is million US$ and it will reach million US in 2025, growing at a CAGR of from 2018; while in China, the market size is valued at xx million US$ and will increase to xx million US in 2025, with a CAGR of xx% during forecast period. In this report, 2017 has been considered as the base year and 2018 to 2025 as
Learn Details of the Cachexia Treatment Market Report
Cachexia is a condition associated with loss of weight and muscle mass in response to a chronic disease. The condition is a symptom of chronic disease such as cancer, diabetes, heart failure, chronic obstructive pulmonary disease etc. Amongst these, cancer is the main cause leading to cachexia. According to a study, it has been estimated that approximately 5 million Americans suffer from this condition. There are different conditions where a
Cancer Cachexia Market Research Report: Analysis & Trends 2024
Cancer cachexia is a complex metabolic condition which leads to progressive weight loss and depletion of host reserves of adipose tissue and skeletal muscle. Cachexia represents the clinical condition out of a chronic, systemic response that leads to rise in buildup of liver proteins and consequent depletion of essential amino acids. Cachexia causes additional problems as the patient becomes more prone to infections and less able to withstand the toxic
Cachexia - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Cachexia - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cachexia – Pipeline Review, H1 2017, provides an overview of the Cachexia (Musculoskeletal Disorders) pipeline landscape. Cachexia is the dramatic weight loss and muscle atrophy seen in patients with chronic illness including type I diabetes, multiple sclerosis,